Assignee
REGEND THERAPEUTICS CO LTD
CN·0 granted patents·3 pending applications·0 citations·filing 2020–2021
Top patents by PatentIndex Score
3 records- 0155US2023000926A1New use of regend001 cell autologous deliverable preparation in treatment of idiopathic pulmonary fibrosisREGEND THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0253US2022226390A1Clinical-grade autologous bronchial basal cell, deliverable formulation, and preparation processREGEND THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 0352US2022380733A1Method for culturing urine-derived kidney stem cells and use thereofREGEND THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when REGEND THERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →